2023-08-16 14:47:43 ET
More on Silence Therapeutics
- Silence Therapeutics: No Reason For It To Fall So Much
- Silence Therapeutics to receive another $4M payment from Hansoh Pharma collaboration
- Silence Therapeutics overweight at Morgan Stanley on RNAi platform
- Silence Therapeutics receives $10M milestone payment from AstraZeneca collaboration
- Silence stock rises ~10% on deal to buy back rights to 2 drug targets from Mallinckrodt
- Seeking Alpha’s Quant Rating on Silence Therapeutics
- Earnings data for Silence Therapeutics
For further details see:
Silence Therapeutics GAAP EPS of -9.60p, revenue of £9.1M